83 Crystallization of Pharmaceutical and Biological Molecules II

Monday, October 29, 2012: 12:30 PM
Allegheny III (Westin )
Description:
This session welcomes papers addressing fundamental as well as applied studies in the area of crystallization of pharmaceutical or biological molecules. Topics related to experimental studies, theory and simulation that contribute to fundamental understanding of crystallization as well as industrial case studies on the crystallization development of pharmaceutical and biological compounds are encouraged.

Sponsor:
Pharmaceuticals
Co-Sponsor(s):
Crystallization and Evaporation (02B)

Chair:
Moiz Diwan
Email: Moiz.Diwan@abbott.com

Co-chairs:
Shailendra V. Bordawekar
Email: shailendra.bordawekar@abbott.com

Sarah L. Perry
Email: perrys@uchicago.edu


12:30 PM
(83a) Robust Particle Size Control During API Crystallization
Nathan Domagalski, Brendan C. Mack, Amanda Rogers, Chenchi Wang, Jose E. Tabora and Lindsay Hobson

12:51 PM
(83b) Effects of an Impurity On the Morphology of an API: Using ATR-FTIR, FBRM and PVM to Confirm a Hypothesis
Christopher S. Polster, Michael A. Lovette, Lori R. Hilden and Christopher L. Burcham

1:12 PM
(83c) Microfluidic Platforms for Time Resolved Laue Crystallography
Sarah L. Perry, Sudipto Guha, Ashtamurthy Pawate, Zhong Ren and Paul J.A. Kenis

1:33 PM
(83d) Crystalline Particle Formation and Polymorphism From Uniform Droplet Evaporation
Kelly M. Carver and Ryan C. Snyder

1:54 PM
(83e) Influence of Additives On Crystal Morphology of Organic Molecular Crystals
Zubin B. Kuvadia and Michael F. Doherty

2:15 PM
Break

2:40 PM
(83g) Integration of Biocatalysis and Crystallization towards the Manufacture of Enantiomerically Pure Compounds
Luis G. Encarnación-Gómez, Andreas S. Bommarius and Ronald W. Rousseau
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division - See also TI: Comprehensive Quality by Design in Pharmaceutical Development and Manufacture
<< Previous Session | Next Session >>